Founder and President
January 2013 - at Present
Mark Hozza built this consultancy focused on providing strategic planning, project management and leadership services for medical device and genomics-based companies. Mark is the sole proprietor, accountable for all aspects of business including marketing, business development, finance, and content delivery. Engaged by Bruker BioSpin to modernize sales processes; subsequently retained for senior-executive position.
Senior Director, Commercial Excellence and Strategic Initiatives
January 2014 - January 2016
During Mark Hozza's time at Bruker BioSpin, he lead modernization of sales processes and establish goals to retain market leading position for this subsidiary of Bruker Corporation specializing in research tools for life sciences sector. Mark directed transformational change and continuous improvement in a global, cross-functional environment, and he also developed processes to ensure FCPA compliance.
President, Head of Commercial Operations in Americas
January 2007 - December 2013
Originally starting at Tecan as Manager of Process Development in 2003, Mark Hozza eventually worked his way up to President and head of commercial operations in the Americas. During his time at Tecan, Mark helped grow the operations in America through a transitional phase of organizational change and market volatility. He managed a staff of 175 and directed finance operations, customer service, IS/IT, quality control, regulatory compliance, HR, and sales/marketing. Mark Hozza was able to maintain
Pharmacology, Cell & Molecular Biology
at SUNY Upstate Medical Center
1989 - 1992 (3 years) New York
at Syracuse University
1985 - 1989 (4 years) New York